Although great strides have been made in the management of heart failure syndromes, the prognosis of cardiogenic shock (CS) remains poor. Indeed, even though the prognosis of patients with CS has improved over time due to aggressive reperfusion strategies, the in-hospital mortality from CS remains about 50%. Most importantly, these results should stimulate a broad investigation of new therapies to address this dreadful clinical problem. The editorial office of Reviews in Cardiovascular Medicine believes that research providing mechanistic insight into CS pathophysiology and management represents one of the most important opportunities to improve knowledge of the present low cardiac output syndrome.
We are seeking submissions of original research and review articles that discuss the pathophysiology of CS; discuss fundamental and clinical research in areas related to this topic; or provides select examples for novel treatments, paradigms, and concepts that have emerged over the past decade.
Prof. Dr. Karim Bendjelid and Dr. Raphael Giraud
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.
- Is VA-ECMO a Rescue Technique or a Treatment in Itself for High-Risk Pulmonary Embolism?Raphaël Giraud, Benjamin Assouline, Karim BendjelidRev. Cardiovasc. Med. 2022, 23(7), 252; https://doi.org/10.31083/j.rcm230725211Download51Views
- Obstructive Shock, from Diagnosis to TreatmentViviane Zotzmann, Felix A. Rottmann, Katharina Müller-Pelzer, Christoph Bode, ... Dawid L. StaudacherRev. Cardiovasc. Med. 2022, 23(7), 248; https://doi.org/10.31083/j.rcm2307248133Download272Views
- Coronary Artery Bypass Grafting in Patients with Acute Myocardial Infarction and Cardiogenic ShockChristina Grothusen, Christine Friedrich, Ulysses Ulbricht, Jette Meinert, ... Jochen CremerRev. Cardiovasc. Med. 2022, 23(7), 237; https://doi.org/10.31083/j.rcm230723718Download107Views
- Venoarterial Extracorporeal Membrane Oxygenation in High-Risk Pulmonary Embolism: A Case Series and Literature ReviewZied Ltaief, Ermes Lupieri, Jean Bonnemain, Nawfel Ben-Hamouda, ... Lucas LiaudetRev. Cardiovasc. Med. 2022, 23(6), 193; https://doi.org/10.31083/j.rcm230619335Download1Citations100Views
- Impella as unloading strategy during VA-ECMO: systematic review and meta-analysisFrancesca Fiorelli, Vasileios PanoulasRev. Cardiovasc. Med. 2021, 22(4), 1503–1511; https://doi.org/10.31083/j.rcm2204154327Download3Citations596Views